| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
|
N Engl J Med
|
2006
|
7.28
|
|
2
|
Warfarin, aspirin, or both after myocardial infarction.
|
N Engl J Med
|
2002
|
6.85
|
|
3
|
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
|
J Am Coll Cardiol
|
2012
|
2.41
|
|
4
|
Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel.
|
Thromb Haemost
|
2014
|
2.29
|
|
5
|
Low heart rates predict incident atrial fibrillation in healthy middle-aged men.
|
Circ Arrhythm Electrophysiol
|
2013
|
2.12
|
|
6
|
Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction).
|
J Am Coll Cardiol
|
2009
|
1.62
|
|
7
|
Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I. Background, epidemiology, animal data, effects on risk factors and safety.
|
Thromb Res
|
2005
|
1.62
|
|
8
|
Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
|
Am J Cardiol
|
2012
|
1.60
|
|
9
|
Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study.
|
Hypertension
|
2012
|
1.57
|
|
10
|
Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
|
Am J Cardiol
|
2007
|
1.48
|
|
11
|
The association between metabolic syndrome and infarct size in patients with acute myocardial infarction.
|
Scand J Clin Lab Invest
|
2010
|
1.45
|
|
12
|
Candesartan in the prevention of relapsing atrial fibrillation.
|
Int J Cardiol
|
2006
|
1.45
|
|
13
|
Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
|
Eur Heart J
|
2013
|
1.44
|
|
14
|
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.
|
Metabolism
|
2007
|
1.42
|
|
15
|
Less benefit from warfarin in diabetics after myocardial infarction?
|
Cardiology
|
2008
|
1.40
|
|
16
|
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
|
Thromb Haemost
|
2013
|
1.36
|
|
17
|
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.
|
Eur Heart J
|
2011
|
1.34
|
|
18
|
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy.
|
Am J Cardiol
|
2010
|
1.30
|
|
19
|
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.
|
Eur Heart J
|
2009
|
1.27
|
|
20
|
The role of interleukin-18 in the metabolic syndrome.
|
Cardiovasc Diabetol
|
2010
|
1.23
|
|
21
|
Antiplatelet agents for the treatment and prevention of atherothrombosis.
|
Eur Heart J
|
2011
|
1.23
|
|
22
|
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
|
Thromb Haemost
|
2009
|
1.21
|
|
23
|
Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects.
|
Scand Cardiovasc J
|
2005
|
1.21
|
|
24
|
Patients' experiences with symptoms and needs in the early rehabilitation phase after coronary artery bypass grafting.
|
Eur J Cardiovasc Nurs
|
2012
|
1.17
|
|
25
|
High prevalence of atrial fibrillation in long-term endurance cross-country skiers: echocardiographic findings and possible predictors--a 28-30 years follow-up study.
|
Eur J Cardiovasc Prev Rehabil
|
2010
|
1.15
|
|
26
|
Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients.
|
Cardiovasc Diabetol
|
2009
|
1.15
|
|
27
|
Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control.
|
Diabetes
|
2002
|
1.14
|
|
28
|
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine.
|
Metabolism
|
2004
|
1.10
|
|
29
|
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.
|
Thromb Res
|
2002
|
1.06
|
|
30
|
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
|
Eur Heart J
|
2010
|
1.05
|
|
31
|
Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia.
|
Am J Clin Nutr
|
2005
|
1.00
|
|
32
|
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
|
Thromb Haemost
|
2013
|
0.99
|
|
33
|
Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up.
|
J Am Coll Cardiol
|
2008
|
0.98
|
|
34
|
Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia.
|
Diabetes Care
|
2008
|
0.98
|
|
35
|
Age and stress related phenotypical changes in bone marrow CD34+ cells.
|
Scand J Clin Lab Invest
|
2009
|
0.95
|
|
36
|
Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study.
|
Eur J Echocardiogr
|
2010
|
0.95
|
|
37
|
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin.
|
Atherosclerosis
|
2003
|
0.94
|
|
38
|
Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia.
|
Eur J Cardiovasc Prev Rehabil
|
2006
|
0.94
|
|
39
|
No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice.
|
Scand Cardiovasc J
|
2002
|
0.93
|
|
40
|
Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design.
|
Scand Cardiovasc J
|
2004
|
0.92
|
|
41
|
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
|
Clin Chim Acta
|
2011
|
0.92
|
|
42
|
Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers.
|
BMC Med
|
2010
|
0.91
|
|
43
|
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
|
Metabolism
|
2013
|
0.90
|
|
44
|
Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men.
|
Am J Cardiol
|
2012
|
0.90
|
|
45
|
Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study.
|
J Cardiovasc Magn Reson
|
2011
|
0.89
|
|
46
|
High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial).
|
J Am Heart Assoc
|
2012
|
0.89
|
|
47
|
Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study.
|
Cardiovasc Diabetol
|
2011
|
0.88
|
|
48
|
Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
|
Clin Sci (Lond)
|
2003
|
0.88
|
|
49
|
The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome.
|
Metab Syndr Relat Disord
|
2009
|
0.87
|
|
50
|
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease.
|
Atherosclerosis
|
2002
|
0.86
|
|
51
|
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
|
Eur J Heart Fail
|
2013
|
0.86
|
|
52
|
Influence of aspirin on inflammatory markers in patients after acute myocardial infarction.
|
Am J Cardiol
|
2003
|
0.86
|
|
53
|
Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men.
|
Metabolism
|
2009
|
0.85
|
|
54
|
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study.
|
Cardiovasc Diabetol
|
2010
|
0.85
|
|
55
|
Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.
|
Thromb J
|
2010
|
0.85
|
|
56
|
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina.
|
Thromb Res
|
2009
|
0.84
|
|
57
|
Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction.
|
Am Heart J
|
2008
|
0.84
|
|
58
|
Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial.
|
J Psychosom Res
|
2007
|
0.84
|
|
59
|
A long-term follow-up study of chest pain patients: effect of panic disorder on mortality, morbidity, and quality of life.
|
Cardiology
|
2007
|
0.84
|
|
60
|
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease.
|
Thromb Res
|
2002
|
0.84
|
|
61
|
Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study.
|
Nutr Metab Cardiovasc Dis
|
2008
|
0.84
|
|
62
|
Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.
|
Thromb Haemost
|
2016
|
0.83
|
|
63
|
The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training.
|
J Card Fail
|
2010
|
0.83
|
|
64
|
The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients.
|
PLoS One
|
2013
|
0.83
|
|
65
|
Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose.
|
Wien Klin Wochenschr
|
2011
|
0.83
|
|
66
|
Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease.
|
Diabetol Metab Syndr
|
2014
|
0.82
|
|
67
|
Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH.
|
Atherosclerosis
|
2006
|
0.82
|
|
68
|
The NORwegian study on DIstrict treatment of ST-elevation myocardial infarction (NORDISTEMI).
|
Scand Cardiovasc J
|
2007
|
0.82
|
|
69
|
Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial.
|
Am Heart J
|
2007
|
0.82
|
|
70
|
Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus.
|
Metab Syndr Relat Disord
|
2012
|
0.82
|
|
71
|
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease.
|
Thromb Haemost
|
2006
|
0.82
|
|
72
|
Soluble tissue factor as predictor of future events in patients with acute myocardial infarction.
|
Thromb Res
|
2003
|
0.82
|
|
73
|
The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel.
|
Thromb J
|
2011
|
0.81
|
|
74
|
Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease.
|
Eur J Cardiovasc Prev Rehabil
|
2006
|
0.81
|
|
75
|
Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment.
|
Thromb J
|
2012
|
0.81
|
|
76
|
Nine-year follow-up of panic disorder in chest pain patients: clinical course and predictors of outcome.
|
Gen Hosp Psychiatry
|
2008
|
0.81
|
|
77
|
Psychological factors, pain attribution and medical morbidity in chest-pain patients with and without coronary artery disease.
|
Gen Hosp Psychiatry
|
2004
|
0.81
|
|
78
|
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
|
Thromb Res
|
2005
|
0.81
|
|
79
|
Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome.
|
Atherosclerosis
|
2009
|
0.81
|
|
80
|
A 1-year follow-up study of chest-pain patients with and without panic disorder.
|
Gen Hosp Psychiatry
|
2006
|
0.81
|
|
81
|
Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training.
|
Scand J Clin Lab Invest
|
2011
|
0.81
|
|
82
|
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
|
Thromb Res
|
2004
|
0.80
|
|
83
|
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers.
|
Br J Nutr
|
2011
|
0.80
|
|
84
|
Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls.
|
Diab Vasc Dis Res
|
2007
|
0.80
|
|
85
|
Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy.
|
Thromb Res
|
2012
|
0.80
|
|
86
|
Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion.
|
Int J Cardiol
|
2008
|
0.80
|
|
87
|
Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men.
|
Thromb Haemost
|
2010
|
0.80
|
|
88
|
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine.
|
Nutr Metab (Lond)
|
2006
|
0.79
|
|
89
|
Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction.
|
Atherosclerosis
|
2002
|
0.79
|
|
90
|
Health-related quality of life after coronary artery bypass grafting. The impact of a randomised controlled home-based intervention program.
|
Qual Life Res
|
2009
|
0.79
|
|
91
|
Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease.
|
Thromb Haemost
|
2006
|
0.78
|
|
92
|
Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study.
|
BMC Geriatr
|
2014
|
0.78
|
|
93
|
Health-related quality of life in non-cardiac chest pain patients with and without panic disorder.
|
Int J Psychiatry Med
|
2008
|
0.78
|
|
94
|
The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients.
|
J Cardiovasc Pharmacol
|
2007
|
0.78
|
|
95
|
Predictors for physical and mental health 6 months after coronary artery bypass grafting: a cohort study.
|
Eur J Cardiovasc Nurs
|
2010
|
0.78
|
|
96
|
Oral anticoagulation after myocardial infarction.
|
Herz
|
2008
|
0.77
|
|
97
|
Improved rate control reduces cardiac troponin T levels in permanent atrial fibrillation.
|
Clin Cardiol
|
2014
|
0.77
|
|
98
|
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study.
|
BMC Endocr Disord
|
2011
|
0.77
|
|
99
|
Association between the factor VII haplotype containing the -402A allele and myocardial infarction in a population of elderly men at high risk for coronary heart disease.
|
Thromb Haemost
|
2005
|
0.77
|
|
100
|
The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene.
|
Thromb Haemost
|
2004
|
0.77
|
|
101
|
The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease.
|
Pathophysiol Haemost Thromb
|
2011
|
0.77
|
|
102
|
Increased levels of endothelial haemostatic markers in patients with coronary heart disease.
|
Thromb Res
|
2002
|
0.77
|
|
103
|
L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation.
|
Cardiology
|
2010
|
0.77
|
|
104
|
Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty).
|
EuroIntervention
|
2015
|
0.77
|
|
105
|
Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction.
|
Eur J Cardiovasc Prev Rehabil
|
2011
|
0.76
|
|
106
|
Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1.
|
Scand Cardiovasc J
|
2010
|
0.76
|
|
107
|
Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris.
|
Scand J Clin Lab Invest
|
2011
|
0.76
|
|
108
|
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.
|
Thromb Res
|
2011
|
0.76
|
|
109
|
The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation. Results from the CAPRAF study, a prospective, randomized, placebo-controlled study.
|
Cardiology
|
2008
|
0.76
|
|
110
|
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy.
|
Thromb J
|
2013
|
0.75
|
|
111
|
Response to Letter by Morris et al regarding article, "Low heart rates predict incident atrial fibrillation in healthy middle-aged men" by Grundvold et al.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.75
|
|
112
|
[Don't withdraw all blood platelet inhibitors].
|
Tidsskr Nor Laegeforen
|
2011
|
0.75
|
|
113
|
Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease.
|
Thromb Res
|
2012
|
0.75
|
|
114
|
Nonfearful panic disorder in chest-pain patients: status after nine-year follow-up.
|
Psychosomatics
|
2008
|
0.75
|
|
115
|
[Exercise ECG and localization of coronary artery stenoses].
|
Tidsskr Nor Laegeforen
|
2004
|
0.75
|
|
116
|
Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
|
Immunobiology
|
2013
|
0.75
|
|
117
|
Prophylaxis against prosthetic mitral valve thrombosis with unfractionated heparin administered by an elastometric infusion pump.
|
Thromb Res
|
2010
|
0.75
|
|
118
|
High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation.
|
Cardiology
|
2015
|
0.75
|
|
119
|
[Secondary prophylaxis after myocardial infarction, bypass surgery and percutaneous coronary intervention].
|
Tidsskr Nor Laegeforen
|
2004
|
0.75
|
|
120
|
[In Process Citation].
|
Tidsskr Nor Laegeforen
|
2016
|
0.75
|
|
121
|
No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure.
|
Scand Cardiovasc J
|
2010
|
0.75
|
|
122
|
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation.
|
Thromb Haemost
|
2009
|
0.75
|
|
123
|
Health-related quality of life after myocardial infarction, does choice of method make a difference?
|
Scand Cardiovasc J
|
2014
|
0.75
|
|
124
|
Effects of angiotensin receptor blockade on serial P-wave signal-averaged electrocardiograms after electrical cardioversion of persistent atrial fibrillation.
|
Europace
|
2009
|
0.75
|
|
125
|
The challenge of judging data on the effects of N-3 fatty acids in CHD.
|
Scand Cardiovasc J
|
2013
|
0.75
|
|
126
|
The relationship between exercise and the healthy heart: trouble in paradise?
|
Expert Rev Cardiovasc Ther
|
2010
|
0.75
|
|
127
|
Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation.
|
Thromb Res
|
2007
|
0.75
|